Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DUSP15 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | EFS | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | ACAP3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | MAGED4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | CASP8AP2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | LRTM2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | NEUROD1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | TLDC1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | BEX1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | COQ8A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |